GTHX Annual ROE
-92.13%
+46.89%+33.73%
31 December 2023
Summary:
As of February 5, 2025, GTHX annual return on equity is -92.13%, with the most recent change of +46.89% (+33.73%) on December 31, 2023. During the last 3 years, it has fallen by -46.27% (-100.89%).GTHX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Quarterly ROE
-118.89%
-45.59%-62.20%
30 June 2024
Summary:
As of February 5, 2025, GTHX quarterly return on equity is -118.89%, with the most recent change of -45.59% (-62.20%) on June 30, 2024. Over the past year, it has increased by +18.30% (+13.34%).GTHX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.7% | +13.3% |
| 3 y3 years | -100.9% | +13.3% |
| 5 y5 years | -144.3% | -318.6% |
GTHX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +144.2% | +319.4% |
G1 Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -118.89%(+62.2%) |
| Mar 2024 | - | -73.30%(-23.7%) |
| Dec 2023 | -92.13%(-33.7%) | -96.05%(-29.3%) |
| Sept 2023 | - | -135.89%(-0.9%) |
| June 2023 | - | -137.19%(-29.0%) |
| Mar 2023 | - | -193.10%(+11.2%) |
| Dec 2022 | -139.02%(+50.4%) | -173.72%(+20.6%) |
| Sept 2022 | - | -144.05%(+18.1%) |
| June 2022 | - | -121.97%(+25.5%) |
| Mar 2022 | - | -97.15%(+25.5%) |
| Dec 2021 | -92.46%(+101.6%) | -77.44%(+17.2%) |
| Sept 2021 | - | -66.06%(+33.2%) |
| June 2021 | - | -49.59%(+10.4%) |
| Mar 2021 | - | -44.93%(-8.5%) |
| Dec 2020 | -45.86% | -49.13%(-0.4%) |
| Sept 2020 | - | -49.35%(-7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | -53.35%(+11.6%) |
| Mar 2020 | - | -47.80%(+16.4%) |
| Dec 2019 | -39.86%(+5.7%) | -41.05%(+19.8%) |
| Sept 2019 | - | -34.27%(+20.7%) |
| June 2019 | - | -28.40%(+0.2%) |
| Mar 2019 | - | -28.35%(-8.8%) |
| Dec 2018 | -37.72%(-57.3%) | -31.08%(-17.3%) |
| Sept 2018 | - | -37.57%(-28.5%) |
| June 2018 | - | -52.55%(-1.9%) |
| Mar 2018 | - | -53.55%(-20.5%) |
| Dec 2017 | -88.43%(-6.1%) | -67.32%(-3.7%) |
| Sept 2017 | - | -69.90%(+3.3%) |
| June 2017 | - | -67.67%(-32.1%) |
| Mar 2017 | - | -99.70%(+40.2%) |
| Dec 2016 | -94.19%(+1.0%) | -71.13% |
| Dec 2015 | -93.25% | - |
FAQ
- What is G1 Therapeutics annual return on equity?
- What is the all time high annual ROE for G1 Therapeutics?
- What is G1 Therapeutics annual ROE year-on-year change?
- What is G1 Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for G1 Therapeutics?
- What is G1 Therapeutics quarterly ROE year-on-year change?
What is G1 Therapeutics annual return on equity?
The current annual ROE of GTHX is -92.13%
What is the all time high annual ROE for G1 Therapeutics?
G1 Therapeutics all-time high annual return on equity is -37.72%
What is G1 Therapeutics annual ROE year-on-year change?
Over the past year, GTHX annual return on equity has changed by +46.89% (+33.73%)
What is G1 Therapeutics quarterly return on equity?
The current quarterly ROE of GTHX is -118.89%
What is the all time high quarterly ROE for G1 Therapeutics?
G1 Therapeutics all-time high quarterly return on equity is -28.35%
What is G1 Therapeutics quarterly ROE year-on-year change?
Over the past year, GTHX quarterly return on equity has changed by +18.30% (+13.34%)